Design, Synthesis and Structure−Activity Relationships of Novel Taxane-Based Multidrug Resistance Reversal AgentsIwao Ojima, Ralph J. Bernacki, Maria R. Baer et al.|Journal of Medicinal Chemistry|2005Cited by 35
Correction to “Identification of Tumor Specific Peptide as EpCAM Ligand and Its Potential Diagnostic and Therapeutic Clinical Application”Xiaowen Ma, Meng Li, David G. Beer et al.|Molecular Pharmaceutics|2019Cited by 0
S1129 Does Rifaximin Treatment Impact Results of Glucose and Lactulose Breath Testing in Patients With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)?Borko Nojkov, William D. Chey, Matthew Kwok et al.|The American Journal of Gastroenterology|2025Cited by 0